SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a late-stage clinical messenger RNA medicines company focused on the development of ...

Arcturus Therapeutics Holdings Inc. ("Arcturus", Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today announced a ...

Arcturus is now a net-cash stock trading below asset value. See why its assets and pipeline look compelling, and what peers ...

Learn more Thermo Fisher Scientific has entered into a strategic collaboration agreement with Arcturus Therapeutics for the ...

Add Yahoo as a preferred source to see more of our stories on Google. Infectious disease experts and public health officials alike are on alert since the World Health Organization (WHO) announced a ...

First detected in India, Omicron subvariant XBB.1.16 - also known as "Arcturus" - has already been reported in over 30 countries. This is what we know about it so far. The World Health Organization ...

The new omicron variant XBB.1.16, better known as arcturus, is now responsible for about 14% of new Covid cases, per the latest data from the Centers for Disease Control and Prevention (CDC). That's ...

Add Yahoo as a preferred source to see more of our stories on Google. A new COVID variant Arcturus has caused a huge uptick in infections in India. (Reuters) Five people in England have died from the ...

At the moment, Arcturus' coronavirus vaccine candidate ARCT-154 is its most advanced project, and it's scheduled to complete its Emergency Use Authorization (EUA) filing in Vietnam by the end of the ...